Recently, Hashdex and the Nasdaq Index Company jointly announced a significant upgrade to the first multi-asset Spot Crypto Assets ETF launched in the United States. This product, named Hashdex Nasdaq Crypto Assets Index ETF (trading code: NCIQ), has added three new Crypto Assets: Ripple (XRP), Solana (SOL), and Stellar (XLM), on top of its existing Bitcoin and Ether base. This expansion has pushed the total market capitalization of the Crypto Assets covered by the ETF beyond the $30 trillion mark.

NCIQ made its debut in the US market in February 2025, marking its first component expansion. After the expansion, the ETF covers five major crypto assets: BTC, ETH, XRP, SOL, and XLM. This initiative provides traditional investors with a low-cost, passively managed diversified crypto assets portfolio, achievable through a single securities account.

From a market perspective, the expansion of NCIQ has multiple significances. First, it lowers the threshold for traditional investors to enter the crypto assets market, providing a more convenient and compliant diversified crypto assets allocation channel. Second, the addition of new components will regularly adjust weights based on the Nasdaq index methodology, which helps better reflect the dynamic changes in the crypto assets market. Finally, this move may attract more incremental funds to pay attention to and flow into the newly included crypto assets, potentially impacting the market performance of these assets.

It is worth noting that the component adjustment mechanism and rebalancing strategy of NCIQ may become an important reference for similar products in the future. With the continuous development and maturation of the crypto assets market, innovative financial products like NCIQ will play an important role in promoting the compliance and mainstreaming process of crypto assets.

For investors, the expansion of NCIQ provides them with a more diversified Crypto Assets investment option. However, considering the high volatility of the Crypto Assets market, investors must still carefully assess their risk tolerance and closely monitor changes in market dynamics and regulatory environments when participating in such products.